A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with previously treated solid tumors that have Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ overexpression.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Nowotwór zaawansowany lub przerzutowy, który pogorszył się po przynajmniej jednym poprzednim leczeniu systemowym
- •Potwierdzony wysoki poziom białka HER2 (IHC 3+) w badaniu centralnym
- •Co najmniej jeden mierzalny guz w badaniu obrazowym
- •Dobry stan ogólny (ECOG 0-1)
- •Przewidywana długość życia co najmniej 3 miesiące
- •Wystarczająca funkcja organów wewnętrznych
- •Ujemny test ciąży u kobiet mogących mieć dzieci
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (28)
Arizona Oncology Associates, PC - NAHOA
Prescott, United States
Rocky Mountain Cancer Center
Littleton, United States
Florida Cancer Specialists - South
Fort Myers, United States
Florida Cancer Specialists - Lake Nona
Orlando, United States
Florida Cancer Specialists - North
St. Petersburg, United States
Florida Cancer Specialists - East
West Palm Beach, United States
Affiliated Oncologists
Chicago Ridge, United States
Barbara Ann Karmanos Cancer Institute
Detroit, United States
Memorial Sloan Kettering Cancer Center
New York, United States
Alliance Cancer Specialists
Horsham, United States
Tennessee Cancer Specialists
Knoxville, United States
SCRI Oncology Partners
Nashville, United States
Texas Oncology - West Texas
Amarillo, United States
Texas Oncology - DFW
Dallas, United States
MD Anderson Cancer Center
Houston, United States
Texas Oncology - San Antonio
San Antonio, United States
Blue Ridge Cancer Care
Roanoke, United States
National Cancer Center Suwon
Suwon, South Korea
The Catholic University of Korea St Vincent's Hospital
Suwon, South Korea
Chonnam National University Hwasun Hospital
Hwasun-Eup, South Korea
Samsung Medical Center
Gangnam-gu, South Korea
Korea University Guro Hospital
Guro-gu, South Korea
Seoul National University Hospital
Jongno-gu, South Korea
Severance Hospital
Seodaemun-gu, South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Seoul National University Bundang Hospital
Seoul, South Korea
Hospital Regional Universitario de Malaga - Hospital General
Málaga, Spain
Trial contact
Clinical Trial Disclosure & Transparency
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.